Retatrutide 5MG
$56.00
Retatrutide 5MG is a 5-milligram format of retatrutide, a synthetic peptide investigated as a multi incretin receptor agonist. Researchers study Retatrutide 5MG in preclinical and early research settings focused on metabolic signaling, energy balance, and glucose related pathways.
In Stock
Retatrutide 5MG is a 5-milligram format of retatrutide, a synthetic peptide studied as a multi incretin receptor agonist in research on metabolic regulation. Studies have examined Retatrutide 5MG in the context of GLP 1, GIP, and glucagon receptor signaling models, with ongoing interest in how these pathways may relate to body weight and glycemic control endpoints.
Because it is a peptide based research compound, retatrutide is typically discussed in terms of receptor pharmacology and downstream metabolic markers rather than therapeutic use. Researchers continue to investigate retatrutide across experimental designs that evaluate appetite signaling, energy expenditure, and glucose homeostasis.
- Specification: 5MG
This product is intended for laboratory and research purposes only. Not for human consumption.
| Weight | 0.2 kg |
|---|---|
| Dimensions | 5 × 5 × 5 cm |
Related Products
Trenbolone Base 50mg ml 10ml refers to trenbolone in a 50 mg per mL concentration across a 10 mL format. Trenbolone is a synthetic anabolic androgenic steroid derived from the 19 nor testosterone scaffold. Researchers have used trenbolone as a reference compound in studies involving androgen receptor signaling and anabolic steroid structure activity relationships.
In Stock
Semaglutide 20MG is a 20 milligram format of semaglutide, a synthetic GLP 1 receptor agonist peptide analogue. It is a 31 amino acid peptide modified for extended stability, and it is widely used in laboratory work involving incretin signaling and metabolic regulation. Researchers study semaglutide in preclinical and translational settings related to glucose homeostasis, appetite pathways, and receptor pharmacology.
In Stock
Winstrol 50mg/ml 10ml refers to a 50 milligram per millilitre, 10 millilitre format commonly associated with stanozolol, a synthetic anabolic androgenic steroid. In research settings, stanozolol has been examined for its interactions with androgen receptor signaling and anabolic androgenic structure activity relationships. Studies have also used it as a reference compound in analytical and anti doping method development.
In Stock
Trenbolone Acetate 75Mg; Trenbolone Enanthate 75Mg; Trenbolone Hexahydrobenzylcarbonate (Parabolan) 75Mg – 200mg/ml, 10 ml is a multi ester trenbolone preparation specified at 200 mg per mL in a 10 mL format. Trenbolone is a synthetic anabolic androgenic steroid derived from 19 nortestosterone, and researchers may use it when studying androgen receptor signaling and steroid structure activity relationships. Work in preclinical and analytical settings has examined trenbolone esters for differences in lipophilicity, hydrolysis rates, and detection profiles.
In Stock
Masteron / Drostanolone Propionate 100mg/ml 10ml is a preparation of drostanolone propionate, an androgenic anabolic steroid derived from dihydrotestosterone. Researchers may reference drostanolone in studies involving androgen receptor signaling and steroid structure activity relationships. It is also encountered in analytical work focused on identification, profiling, and method development for anabolic agents.
In Stock
Semaglutide 30MG is a 30-milligram format of semaglutide, a synthetic GLP-1 receptor agonist peptide analogue. Researchers study semaglutide in the context of incretin signaling, glucose regulation pathways, and appetite related neuroendocrine models. It is a modified peptide designed to extend stability relative to native GLP-1.
In Stock
Trenbolone Enanthate (Tre) 100mg/ml 10ml is an oil based preparation of trenbolone enanthate, a synthetic anabolic androgenic steroid ester derived from 19 nor testosterone chemistry. Researchers may reference trenbolone esters in studies involving androgen receptor signaling, nitrogen balance models, and steroid pharmacokinetics. This format is commonly discussed in analytical and method development work where concentration and volume are specified.
In Stock
Semaglutide 2MG is a 2-milligram format of semaglutide, a synthetic GLP 1 receptor agonist peptide analogue. It is studied in pharmacology and metabolic research as a long acting incretin mimetic. Researchers examine semaglutide in receptor signaling and glucose homeostasis models.
In Stock
Trenbolone Acetate 100Mg; Drostanolone Propionate 100Mg; Testosterone Propionate 100Mg – 300mg/ml, 10ml is a multi compound anabolic androgenic steroid blend specified at 300mg/ml in a 10ml format. Trenbolone acetate is a 19 nor testosterone derivative, while drostanolone and testosterone propionate are DHT derived and testosterone based esters used in androgen research. Researchers may examine combined esterified androgens in models involving receptor binding, anabolic androgenic signaling, and pharmacokinetic comparisons.
In Stock
Trenbolone Acetate 75Mg, Trenbolone Enanthate 125Mg – 200mg/ml, 10 ml is a combined format of trenbolone in two ester forms: acetate and enanthate. Trenbolone is a synthetic anabolic androgenic steroid derived from 19-nortestosterone and widely referenced in endocrine and receptor binding research. Studies have examined esterified trenbolone in the context of androgen receptor signaling, pharmacokinetics, and steroid structure activity relationships.
In Stock
Cagrilintide + Semaglutide 5MG is a 5-milligram combined format of two peptide research compounds: cagrilintide (an amylin analogue) and semaglutide (a GLP 1 receptor agonist peptide analogue). Researchers study this pairing in preclinical and clinical research settings focused on appetite regulation and metabolic signaling. Studies have examined how amylin and GLP 1 pathways may interact when investigated together.
In Stock
Semaglutide 5MG is a 5-milligram format of semaglutide, a synthetic GLP 1 receptor agonist peptide analogue. It is studied as an acylated peptide engineered for extended stability in biological systems. Researchers have examined semaglutide in preclinical and translational work involving incretin signaling and metabolic regulation pathways.
In Stock
